Page 254 - 201904
P. 254
·780· 精细化工 FINE CHEMICALS 第 36 卷
如表 4 所示,过量的甲酰胺有利于偶联反应的 positive non-small-cell lung cancer (ARCHER 1050): a randomised,
进行,目标产物收率显著提高(No.1~4);当甲酰胺 open-label, phase 3 trial[J]. Lancet Oncology, 2017, 18(11):
1454-1466.
用量增加为 BA 的 2 倍后,目标产物收率增加不明 [3] Huang Ziling (黄子凌), Huang Lanshan (黄兰姗), Shen Siqiao (沈思
显(No.3~4)。在 CuI/4-羟基-L-脯氨酸的作用下, 乔), et al. The influence on cell proliferation and apoptosis of
combined afatinib with Mithramycin A in human hepatocellular
偶联和环化反应在较低温度下即可进行,但目标产
carcinoma cell line HepG2[J]. ACTA Universitatis Medicinalis
物收率较低(No.5~6);当反应温度升高至 80 ℃时, Nanjing (Natural Science) (南京医科大学学报: 自然科学版),
目标产物收率最高(No.3);继续升高反应温度,目 2015, (5): 638-643.
[4] Wang Shengqi (王胜奇). The reversal effect of afatinib on ABCB1-
标产物收率有所下降(No.7)。在微波促进下,偶联
mediated multidruf resistance in human ovarian cancer and its
和环化反应 10 min 即可较好地完成;延长反应时间, mechanisms[D]. Guangzhou: Southern Medical University Guangzhou
目标产物收率反而降低(No.9~10)。 (南方医科大学), 2016.
[5] Zhao Ying (赵颖), Chi Jiangrui (迟江瑞), Zhao Hongmeng (赵洪猛),
综上所述,合成 QA 的优化反应条件为:BA
et al. Effect of afatinib on the proliferation and apoptosis of human
5 mmol,甲酰胺 10 mmol,CuI 用量 10%,4-羟基-L- breast cell lines and its mechanisms[J]. Chinese Journal of Clinical
脯氨酸用量 10%,碳酸钾 10 mmol,DMF 10 mL,微 Oncology (中国肿瘤临床), 2017, 44(15): 739-743.
[6] Hartmann S, Zwick L, Maurus K, et al. Melanoma-associated antigen
波(200 W)辐射 80 ℃反应 10 min。在此条件下, A11 reduces erlotinib and afatinib efficacy in head and neck cancer
QA 的收率为 96.4%。 [J]. Journal of Cranio-Maxillofacial Surgery, 2018, 46(3): 492-497.
[7] Endersby R, Whitehouse J, Hii H, et al. A pre-clinical assessment of
3 结论 the pan-ERBB inhibitor dacomitinib in pediatric and adult brain
tumors[J]. Neoplasia, 2018, 20(5): 432-442.
[8] Cavalieri S, Perrone F, Miceli R, et al. Efficacy and safety of
以 2-溴-4-氟-5-硝基苯甲腈为原料,在 CuI 和微
single-agent pan-human epidermal growth factor receptor (HER)
波促进下,与 3-氯-4-氟苯胺发生加成反应得到中 inhibitor dacomitinib in locally advanced unresectable or metastatic
间产物 BA,收率 93.8%,得到的优化反应条件为: skin squamous cell cancer[J]. European Journal of Cancer, 2018, 97:
7-15.
2-溴-4-氟-5-硝基苯甲腈 10 mmol,3-氯-4-氟苯胺
[9] Tu Yuanbiao (涂远彪), Wang Min (王敏), Sun Chao (孙超), et al.
10 mmol,CuI 用量 20%,无水乙醇 10 mL,微波 Synthesis and optimization of antitumor agent afatinib[J]. Chemical
(200 W)辐射回流反应 20 min;然后,以 CuI/4- Reagents (化学试剂), 2016, 38(8): 795-799.
[10] Cheng Haibo (程海博), Xu Bin (徐斌), Zhang Huibin (张惠斌), et
羟基-L-脯氨酸作催化剂,碳酸钾作碱,微波促进下 al. Synthetic process of antitumor drug dacomitinib[J]. Journal of
与甲酰胺发生串联的胺化和缩合环化反应,以 China Pharmaceutical University Nanjing (中国药科大学学报),
96.4%的收率得到目标产物 QA,得到的优化反应条 2014, 45(2): 165-169.
[11] Soyka R, Rall W, Schnaubelt J, et al. Process for preparing amino
件为:BA 5 mmol,甲酰胺 10 mmol,CuI 和 4-羟基-L- crotonyl compound:US2007/0027170A1[P]. 2007-02-01.
脯氨酸用量均为 10%,碳酸钾 10 mmol,DMF [12] Zhang Q, Zhu H. Novel quinazoline derivatives: US2013/0035350A1
10 mL,微波(200 W)辐射 80 ℃反应 10 min。该 [P]. 2013-02-07.
[13] Cha M Y, Lee K, Woo J, et al. Discovery of a novel Her-1/Her-2 dual
方法合成路线短,反应条件温和,反应时间短,产 tyrosine kinase inhibitor for the treatment of Her-1 selective inhibitor-
物收率高,避免使用氯化亚砜和三氯氧磷,对环境 resistant non-small cell lung cancer[J]. J Med Chem, 2009, 52: 6880-
较为友好,为合成 4-喹唑啉胺类化合物提供了一种 6888.
[14] Liu Changchun (刘长春). Synthesis of 2,6-dimethyl-3-aryl-4 (1H)-
高效的简便方法,具有潜在的工业化应用前景。 quinolones under microwave irradiation[J]. Fine Chemicals (精细化
工), 2014, 31(1): 75-78.
参考文献: [15] Zong Chaoyang (纵朝阳), Gu Huiwen (顾惠雯), Zhang Lijie (张立
[1] Wang Debby D, Lee Victor H F, Zhu Guangyu, et al. Selectivity 洁), et al. Microwave-accelerated Dimroth rearrangement for the
profile of afatinib for EGFR-mutated non-small-cell lung cancer[J]. synthesis of pyrido [2,3-d] pyrimidin-4-amine derivatives[J]. Chin J
Mol Biosyst, 2016, 12: 1552-1563. Org Chem (有机化学), 2018, 38(5): 1165-1171.
[2] Wu Yilong, Cheng Ying, Zhou Xiangdong, et al. Dacomitinib versus [16] Zhang W, Su W G, Yang H, et al. Quinazoline derivatives: US2013/
gefitinib as first-line treatment for patients with EGFR-mutation- 0217761A1[P]. 2013-08-22.